Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Rockwell Medical IN (RMTI)

Rockwell Medical IN (RMTI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 147,808
  • Shares Outstanding, K 69,069
  • Annual Sales, $ 61,300 K
  • Annual Income, $ -34,130 K
  • 60-Month Beta 1.48
  • Price/Sales 2.31
  • Price/Cash Flow N/A
  • Price/Book 6.72

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate -0.13
  • Number of Estimates 1
  • High Estimate -0.13
  • Low Estimate -0.13
  • Prior Year -0.18
  • Growth Rate Est. (year over year) +27.78%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.95 +9.74%
on 05/14/20
2.53 -15.39%
on 05/06/20
-0.26 (-10.83%)
since 04/27/20
3-Month
1.31 +63.86%
on 03/16/20
3.85 -44.42%
on 03/06/20
-0.79 (-26.96%)
since 02/27/20
52-Week
1.31 +63.86%
on 03/16/20
4.90 -56.33%
on 05/29/19
-2.58 (-54.66%)
since 05/24/19

Most Recent Stories

More News
Rockwell Medical, Inc. Files New Drug Submission with Health Canada for Marketing Approval of Triferic(R) AVNU(TM)

Rockwell Medical, Inc. (Nasdaq: RMTI) ("Rockwell Medical" or the "Company"), a biopharmaceutical company dedicated to transforming anemia management and improving outcomes for patients around the world,...

RMTI : 2.14 (+4.39%)
Rockwell Medical (RMTI) Reports Q1 Loss, Tops Revenue Estimates

Rockwell Medical (RMTI) delivered earnings and revenue surprises of 0.00% and 0.96%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

RMTI : 2.14 (+4.39%)
Rockwell Medical: 1Q Earnings Snapshot

HACKENSACK, N.J. (AP) _ Rockwell Medical Inc. (RMTI) on Monday reported a loss of $8 million in its first quarter.

RMTI : 2.14 (+4.39%)
Will Rockwell Medical (RMTI) Report Negative Q1 Earnings? What You Should Know

Rockwell Medical (RMTI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

RMTI : 2.14 (+4.39%)
Rockwell Medical, Inc. Appoints Russell H. Ellison, M.D., M.Sc., as President and Chief Executive Officer

Rockwell Medical, Inc. (Nasdaq: RMTI) ("Rockwell Medical" or the "Company"), a biopharmaceutical company dedicated to transforming anemia management and improving outcomes for patients around the world,...

RMTI : 2.14 (+4.39%)
Rockwell Medical, Inc. Appoints Pharmaceutical Industry Leader Robert S. Radie to Board of Directors

Rockwell Medical, Inc. (NASDAQ:RMTI) ("Rockwell Medical" or the "Company"), a biopharmaceutical company dedicated to transforming anemia management and improving outcomes for patients around the world,...

RMTI : 2.14 (+4.39%)
MRAG Plans to Fight for Rockwell Medical Shareholders' Right to Vote for New Directors and Improved Board Governance

MRAG Believes Recent Debt Financing Not in the Best Interest of Rockwell Shareholders

RMTI : 2.14 (+4.39%)
Rockwell Medical, Inc. Confirms Medical Resource Acquisition Group's Director Nominations Are Invalid

Rockwell Medical, Inc. (NASDAQ:RMTI) ("Rockwell Medical" or the "Company"), a biopharmaceutical company dedicated to transforming anemia management and improving outcomes for patients around the world,...

RMTI : 2.14 (+4.39%)
Medical Resource Acquisition Group, LLC is Focused on Replacing Rockwell Medical Directors to Balance the Board, Improve Governance and Bring Much-Needed Transparency to RMTI Shareholders

Medical Resource Acquisition Group, LLC (MRAG), an investment company focused on facilitating the advancement of innovative healthcare companies, announces that it remains focused on replacing Rockwell...

RMTI : 2.14 (+4.39%)
Rockwell Medical, Inc. Announces $35 Million Debt Financing Agreement with Innovatus Capital Partners, LLC

Rockwell Medical, Inc. (NASDAQ:RMTI) ("Rockwell Medical" or the "Company"), a biopharmaceutical company dedicated to transforming anemia management and improving outcomes for patients around the world,...

RMTI : 2.14 (+4.39%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Sell with a Average short term outlook on maintaining the current direction.

See More Share

Trade RMTI with:

Business Summary

Rockwell Medical Technologies, Inc. manufactures hemodialysis concentrates and dialysis kits, and sells, distributes and delivers such concentrates and dialysis kits, as well as other ancillary hemodialysis products, to hemodialysis providers in the United States. Hemodialysis is a process which is able...

See More

Key Turning Points

2nd Resistance Point 2.27
1st Resistance Point 2.21
Last Price 2.14
1st Support Level 2.04
2nd Support Level 1.93

See More

52-Week High 4.90
Fibonacci 61.8% 3.53
Fibonacci 50% 3.10
Fibonacci 38.2% 2.68
Last Price 2.14
52-Week Low 1.31

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar